Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice

Ingrid W. Asterholm, Joseph M. Rutkowski, Teppei Fujikawa, You Ree Cho, Makoto Fukuda, Caroline Tao, Zhao V. Wang, Rana K. Gupta, Joel K. Elmquist, Philipp E. Scherer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aims/hypothesis: Resistin was originally identified as an adipocyte-derived factor upregulated during obesity and as a contributor to obesity-associated insulin resistance. Clinically, resistin has also been implicated in cardiovascular disease in a number of different patient populations. Our aim was to simultaneously address these phenomena. Methods: We generated mice with modest adipocyte-specific resistin overexpression. These mice were crossed with mice deficient in the LDL receptor (Ldlr -/-) to probe the physiological role of resistin. Both metabolic and atherosclerotic assessments were performed. Results: Resistin overexpression led to increased atherosclerotic progression in Ldlr -/- mice. This was in part related to elevated serum triacylglycerol levels and a reduced ability to clear triacylglycerol upon a challenge. Additional phenotypic changes, such as increased body weight and reduced glucose clearance, independent of the Ldlr -/- background, confirmed increased adiposity associated with a more pronounced insulin resistance. A hallmark of elevated resistin was the disproportionate increase in circulating leptin levels. These mice thus recapitulated both the proposed negative cardiovascular correlation and the insulin resistance. A unifying mechanism for this complex phenotype was a resistin-mediated central leptin resistance, which we demonstrate directly both in vivo and in organotypic brain slices. In line with reduced sympathetic nervous system outflow, we found decreased brown adipose tissue (BAT) activity. The resulting elevated triacylglycerol levels provide a likely explanation for accelerated atherosclerosis. Conclusions/interpretation: Resistin overexpression leads to a complex metabolic phenotype driven by resistin-mediated central leptin resistance and reduced BAT activity. Hypothalamic leptin resistance thus provides a unifying mechanism for both resistin-mediated insulin resistance and enhanced atherosclerosis.

Original languageEnglish (US)
Pages (from-to)1209-1218
Number of pages10
JournalDiabetologia
Volume57
Issue number6
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Resistin
Leptin
Insulin Resistance
LDL Receptors
Triglycerides
Brown Adipose Tissue
Adipocytes
Atherosclerosis
Obesity
Phenotype
Sympathetic Nervous System
Adiposity
Cardiovascular Diseases
Body Weight

Keywords

  • Adipose tissue
  • Atherosclerosis
  • Brown adipose tissue
  • Insulin resistance
  • Leptin
  • Leptin resistance
  • Obesity
  • Resistin
  • Triacylglycerol
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Asterholm, I. W., Rutkowski, J. M., Fujikawa, T., Cho, Y. R., Fukuda, M., Tao, C., ... Scherer, P. E. (2014). Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. Diabetologia, 57(6), 1209-1218. https://doi.org/10.1007/s00125-014-3210-3

Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. / Asterholm, Ingrid W.; Rutkowski, Joseph M.; Fujikawa, Teppei; Cho, You Ree; Fukuda, Makoto; Tao, Caroline; Wang, Zhao V.; Gupta, Rana K.; Elmquist, Joel K.; Scherer, Philipp E.

In: Diabetologia, Vol. 57, No. 6, 01.01.2014, p. 1209-1218.

Research output: Contribution to journalArticle

Asterholm, IW, Rutkowski, JM, Fujikawa, T, Cho, YR, Fukuda, M, Tao, C, Wang, ZV, Gupta, RK, Elmquist, JK & Scherer, PE 2014, 'Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice', Diabetologia, vol. 57, no. 6, pp. 1209-1218. https://doi.org/10.1007/s00125-014-3210-3
Asterholm, Ingrid W. ; Rutkowski, Joseph M. ; Fujikawa, Teppei ; Cho, You Ree ; Fukuda, Makoto ; Tao, Caroline ; Wang, Zhao V. ; Gupta, Rana K. ; Elmquist, Joel K. ; Scherer, Philipp E. / Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. In: Diabetologia. 2014 ; Vol. 57, No. 6. pp. 1209-1218.
@article{34a36ed75c82468fa115e7cb93ba8ac0,
title = "Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice",
abstract = "Aims/hypothesis: Resistin was originally identified as an adipocyte-derived factor upregulated during obesity and as a contributor to obesity-associated insulin resistance. Clinically, resistin has also been implicated in cardiovascular disease in a number of different patient populations. Our aim was to simultaneously address these phenomena. Methods: We generated mice with modest adipocyte-specific resistin overexpression. These mice were crossed with mice deficient in the LDL receptor (Ldlr -/-) to probe the physiological role of resistin. Both metabolic and atherosclerotic assessments were performed. Results: Resistin overexpression led to increased atherosclerotic progression in Ldlr -/- mice. This was in part related to elevated serum triacylglycerol levels and a reduced ability to clear triacylglycerol upon a challenge. Additional phenotypic changes, such as increased body weight and reduced glucose clearance, independent of the Ldlr -/- background, confirmed increased adiposity associated with a more pronounced insulin resistance. A hallmark of elevated resistin was the disproportionate increase in circulating leptin levels. These mice thus recapitulated both the proposed negative cardiovascular correlation and the insulin resistance. A unifying mechanism for this complex phenotype was a resistin-mediated central leptin resistance, which we demonstrate directly both in vivo and in organotypic brain slices. In line with reduced sympathetic nervous system outflow, we found decreased brown adipose tissue (BAT) activity. The resulting elevated triacylglycerol levels provide a likely explanation for accelerated atherosclerosis. Conclusions/interpretation: Resistin overexpression leads to a complex metabolic phenotype driven by resistin-mediated central leptin resistance and reduced BAT activity. Hypothalamic leptin resistance thus provides a unifying mechanism for both resistin-mediated insulin resistance and enhanced atherosclerosis.",
keywords = "Adipose tissue, Atherosclerosis, Brown adipose tissue, Insulin resistance, Leptin, Leptin resistance, Obesity, Resistin, Triacylglycerol, Type 2 diabetes",
author = "Asterholm, {Ingrid W.} and Rutkowski, {Joseph M.} and Teppei Fujikawa and Cho, {You Ree} and Makoto Fukuda and Caroline Tao and Wang, {Zhao V.} and Gupta, {Rana K.} and Elmquist, {Joel K.} and Scherer, {Philipp E.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00125-014-3210-3",
language = "English (US)",
volume = "57",
pages = "1209--1218",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice

AU - Asterholm, Ingrid W.

AU - Rutkowski, Joseph M.

AU - Fujikawa, Teppei

AU - Cho, You Ree

AU - Fukuda, Makoto

AU - Tao, Caroline

AU - Wang, Zhao V.

AU - Gupta, Rana K.

AU - Elmquist, Joel K.

AU - Scherer, Philipp E.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aims/hypothesis: Resistin was originally identified as an adipocyte-derived factor upregulated during obesity and as a contributor to obesity-associated insulin resistance. Clinically, resistin has also been implicated in cardiovascular disease in a number of different patient populations. Our aim was to simultaneously address these phenomena. Methods: We generated mice with modest adipocyte-specific resistin overexpression. These mice were crossed with mice deficient in the LDL receptor (Ldlr -/-) to probe the physiological role of resistin. Both metabolic and atherosclerotic assessments were performed. Results: Resistin overexpression led to increased atherosclerotic progression in Ldlr -/- mice. This was in part related to elevated serum triacylglycerol levels and a reduced ability to clear triacylglycerol upon a challenge. Additional phenotypic changes, such as increased body weight and reduced glucose clearance, independent of the Ldlr -/- background, confirmed increased adiposity associated with a more pronounced insulin resistance. A hallmark of elevated resistin was the disproportionate increase in circulating leptin levels. These mice thus recapitulated both the proposed negative cardiovascular correlation and the insulin resistance. A unifying mechanism for this complex phenotype was a resistin-mediated central leptin resistance, which we demonstrate directly both in vivo and in organotypic brain slices. In line with reduced sympathetic nervous system outflow, we found decreased brown adipose tissue (BAT) activity. The resulting elevated triacylglycerol levels provide a likely explanation for accelerated atherosclerosis. Conclusions/interpretation: Resistin overexpression leads to a complex metabolic phenotype driven by resistin-mediated central leptin resistance and reduced BAT activity. Hypothalamic leptin resistance thus provides a unifying mechanism for both resistin-mediated insulin resistance and enhanced atherosclerosis.

AB - Aims/hypothesis: Resistin was originally identified as an adipocyte-derived factor upregulated during obesity and as a contributor to obesity-associated insulin resistance. Clinically, resistin has also been implicated in cardiovascular disease in a number of different patient populations. Our aim was to simultaneously address these phenomena. Methods: We generated mice with modest adipocyte-specific resistin overexpression. These mice were crossed with mice deficient in the LDL receptor (Ldlr -/-) to probe the physiological role of resistin. Both metabolic and atherosclerotic assessments were performed. Results: Resistin overexpression led to increased atherosclerotic progression in Ldlr -/- mice. This was in part related to elevated serum triacylglycerol levels and a reduced ability to clear triacylglycerol upon a challenge. Additional phenotypic changes, such as increased body weight and reduced glucose clearance, independent of the Ldlr -/- background, confirmed increased adiposity associated with a more pronounced insulin resistance. A hallmark of elevated resistin was the disproportionate increase in circulating leptin levels. These mice thus recapitulated both the proposed negative cardiovascular correlation and the insulin resistance. A unifying mechanism for this complex phenotype was a resistin-mediated central leptin resistance, which we demonstrate directly both in vivo and in organotypic brain slices. In line with reduced sympathetic nervous system outflow, we found decreased brown adipose tissue (BAT) activity. The resulting elevated triacylglycerol levels provide a likely explanation for accelerated atherosclerosis. Conclusions/interpretation: Resistin overexpression leads to a complex metabolic phenotype driven by resistin-mediated central leptin resistance and reduced BAT activity. Hypothalamic leptin resistance thus provides a unifying mechanism for both resistin-mediated insulin resistance and enhanced atherosclerosis.

KW - Adipose tissue

KW - Atherosclerosis

KW - Brown adipose tissue

KW - Insulin resistance

KW - Leptin

KW - Leptin resistance

KW - Obesity

KW - Resistin

KW - Triacylglycerol

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84901196379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901196379&partnerID=8YFLogxK

U2 - 10.1007/s00125-014-3210-3

DO - 10.1007/s00125-014-3210-3

M3 - Article

VL - 57

SP - 1209

EP - 1218

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -